JP2019518438A5 - - Google Patents

Download PDF

Info

Publication number
JP2019518438A5
JP2019518438A5 JP2018556983A JP2018556983A JP2019518438A5 JP 2019518438 A5 JP2019518438 A5 JP 2019518438A5 JP 2018556983 A JP2018556983 A JP 2018556983A JP 2018556983 A JP2018556983 A JP 2018556983A JP 2019518438 A5 JP2019518438 A5 JP 2019518438A5
Authority
JP
Japan
Prior art keywords
snv
target
sample
nucleic acid
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018556983A
Other languages
English (en)
Japanese (ja)
Other versions
JP7630902B2 (ja
JP2019518438A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/030293 external-priority patent/WO2017190106A1/en
Publication of JP2019518438A publication Critical patent/JP2019518438A/ja
Publication of JP2019518438A5 publication Critical patent/JP2019518438A5/ja
Priority to JP2022135767A priority Critical patent/JP2022180384A/ja
Application granted granted Critical
Publication of JP7630902B2 publication Critical patent/JP7630902B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018556983A 2016-04-29 2017-04-29 多重/最適化ミスマッチ増幅(moma)-標的数 Active JP7630902B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2022135767A JP2022180384A (ja) 2016-04-29 2022-08-29 多重/最適化ミスマッチ増幅(moma)-標的数

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662330053P 2016-04-29 2016-04-29
US62/330,053 2016-04-29
PCT/US2017/030293 WO2017190106A1 (en) 2016-04-29 2017-04-29 Multiplexed optimized mismatch amplification (moma)-target number

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2022135767A Division JP2022180384A (ja) 2016-04-29 2022-08-29 多重/最適化ミスマッチ増幅(moma)-標的数

Publications (3)

Publication Number Publication Date
JP2019518438A JP2019518438A (ja) 2019-07-04
JP2019518438A5 true JP2019518438A5 (enExample) 2020-06-18
JP7630902B2 JP7630902B2 (ja) 2025-02-18

Family

ID=60161206

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018556983A Active JP7630902B2 (ja) 2016-04-29 2017-04-29 多重/最適化ミスマッチ増幅(moma)-標的数
JP2022135767A Pending JP2022180384A (ja) 2016-04-29 2022-08-29 多重/最適化ミスマッチ増幅(moma)-標的数

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2022135767A Pending JP2022180384A (ja) 2016-04-29 2022-08-29 多重/最適化ミスマッチ増幅(moma)-標的数

Country Status (11)

Country Link
US (1) US20190153521A1 (enExample)
EP (2) EP3449019B1 (enExample)
JP (2) JP7630902B2 (enExample)
CN (1) CN109661475A (enExample)
AU (1) AU2017258801A1 (enExample)
BR (1) BR112018072196A2 (enExample)
CA (1) CA3022572A1 (enExample)
EA (1) EA201892489A1 (enExample)
IL (1) IL262642A (enExample)
MX (1) MX2018013224A (enExample)
WO (1) WO2017190106A1 (enExample)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9424392B2 (en) 2005-11-26 2016-08-23 Natera, Inc. System and method for cleaning noisy genetic data from target individuals using genetic data from genetically related individuals
US10316362B2 (en) 2010-05-18 2019-06-11 Natera, Inc. Methods for simultaneous amplification of target loci
US12152275B2 (en) 2010-05-18 2024-11-26 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US20190010543A1 (en) 2010-05-18 2019-01-10 Natera, Inc. Methods for simultaneous amplification of target loci
US11939634B2 (en) 2010-05-18 2024-03-26 Natera, Inc. Methods for simultaneous amplification of target loci
US11339429B2 (en) 2010-05-18 2022-05-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US12221653B2 (en) 2010-05-18 2025-02-11 Natera, Inc. Methods for simultaneous amplification of target loci
US11326208B2 (en) 2010-05-18 2022-05-10 Natera, Inc. Methods for nested PCR amplification of cell-free DNA
US11408031B2 (en) 2010-05-18 2022-08-09 Natera, Inc. Methods for non-invasive prenatal paternity testing
CA3207599A1 (en) 2010-05-18 2011-11-24 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11332793B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for simultaneous amplification of target loci
US11332785B2 (en) 2010-05-18 2022-05-17 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US11322224B2 (en) 2010-05-18 2022-05-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
US9677118B2 (en) 2014-04-21 2017-06-13 Natera, Inc. Methods for simultaneous amplification of target loci
BR112013020220B1 (pt) 2011-02-09 2020-03-17 Natera, Inc. Método para determinar o estado de ploidia de um cromossomo em um feto em gestação
US20140100126A1 (en) 2012-08-17 2014-04-10 Natera, Inc. Method for Non-Invasive Prenatal Testing Using Parental Mosaicism Data
EP3134541B1 (en) 2014-04-21 2020-08-19 Natera, Inc. Detecting copy number variations (cnv) of chromosomal segments in cancer
US20180173846A1 (en) 2014-06-05 2018-06-21 Natera, Inc. Systems and Methods for Detection of Aneuploidy
US11479812B2 (en) 2015-05-11 2022-10-25 Natera, Inc. Methods and compositions for determining ploidy
RU2760913C2 (ru) 2016-04-15 2021-12-01 Натера, Инк. Способы выявления рака легкого
WO2018067517A1 (en) 2016-10-04 2018-04-12 Natera, Inc. Methods for characterizing copy number variation using proximity-litigation sequencing
CA3042722A1 (en) * 2016-11-02 2018-05-11 The Medical College Of Wisconsin, Inc. Methods for assessing risk using mismatch amplification and statistical methods
GB201618485D0 (en) 2016-11-02 2016-12-14 Ucl Business Plc Method of detecting tumour recurrence
US10011870B2 (en) 2016-12-07 2018-07-03 Natera, Inc. Compositions and methods for identifying nucleic acid molecules
CA3067637A1 (en) 2017-06-20 2018-12-27 The Medical College Of Wisconsin, Inc. Assessing transplant complication risk with total cell-free dna
US12084720B2 (en) 2017-12-14 2024-09-10 Natera, Inc. Assessing graft suitability for transplantation
US12024738B2 (en) 2018-04-14 2024-07-02 Natera, Inc. Methods for cancer detection and monitoring
WO2019217918A1 (en) * 2018-05-10 2019-11-14 The Medical College Of Wisconsin, Inc. Multiplexed optimized mismatch amplification (moma)-cancer risk assessment with non-cancer associated targets
US12234509B2 (en) 2018-07-03 2025-02-25 Natera, Inc. Methods for detection of donor-derived cell-free DNA
WO2020105058A1 (en) * 2018-11-25 2020-05-28 Azulay Chen Methods for measuring small nucleic acid abundance differences
US11931674B2 (en) 2019-04-04 2024-03-19 Natera, Inc. Materials and methods for processing blood samples
WO2020247263A1 (en) 2019-06-06 2020-12-10 Natera, Inc. Methods for detecting immune cell dna and monitoring immune system
US12023370B2 (en) * 2021-04-08 2024-07-02 Anticancer Inc. Composition for the treatment of COVID-19 infection, and a method of treatment

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1599608A4 (en) * 2003-03-05 2007-07-18 Genetic Technologies Ltd Identification of fetal DNA and fetal cell marker in maternal plasma or serum
US20130071844A1 (en) 2010-03-24 2013-03-21 Toppan Printing Co., Ltd. Method for detecting target base sequence using competitive primer
UA115321C2 (uk) * 2011-12-16 2017-10-25 Басф Агрокемікал Продактс Б.В. Спосіб та комплект для аналізу ahasl генів у рослин
WO2013159035A2 (en) * 2012-04-19 2013-10-24 Medical College Of Wisconsin, Inc. Highly sensitive surveillance using detection of cell free dna
US20140242582A1 (en) 2013-02-28 2014-08-28 Ariosa Diagnostics, Inc. Detection of genetic abnormalities using ligation-based detection and digital pcr
WO2014143989A1 (en) * 2013-03-15 2014-09-18 Medical College Of Wisconsin, Inc. Fetal well being surveillance using fetal specific cell free dna
SI3004388T2 (sl) 2013-05-29 2023-11-30 Chronix Biomedical Odkrivanje in kvantifikacija donorjeve brezcelične DNK v cirkulaciji prejemnikov presajenih organov
WO2015178978A2 (en) * 2014-02-14 2015-11-26 The Board Of Regents Of The University Of Texas System Strand exchange hairpin primers that give high allelic discrimination
HK1252152A1 (zh) 2015-04-30 2019-05-17 Medical College Of Wisconsin, Inc. 用於評估無細胞dna的多重優化錯配擴增(moma)實時pcr

Similar Documents

Publication Publication Date Title
JP2019518438A5 (enExample)
JP2022180384A5 (enExample)
JP2019514387A5 (enExample)
JP2022002508A5 (enExample)
JP2018514219A5 (enExample)
JP2019518437A5 (enExample)
JP2019534017A5 (enExample)
US11479819B2 (en) Non-invasive method for monitoring transplanted organ status in organ-transplant recipients
BR112018015871B1 (pt) Sistema, método e dispositivo para detectar a presença de uma sequência alvo de ácido nucleico em uma amostra
CN107206043A (zh) 使用机器学习和高维转录数据在经支气管活检上诊断特发性肺纤维化的系统和方法
TWI715900B (zh) 次世代定序儀用引子以及其製造方法、使用次世代定序儀用引子之dna庫以及其製造方法,及使用dna庫之基因體dna解析方法
Elmahgoub et al. Prevalence of coagulation factor XIII and plasminogen activator inhibitor-1 gene polymorphisms among Egyptian women suffering from unexplained primary recurrent miscarriage
EP2999800A2 (en) Measures of short telomere abundance
Bartley et al. A DNA real-time quantitative PCR method suitable for routine monitoring of low levels of minimal residual disease in chronic myeloid leukemia
CN107922940A (zh) 从ffpe组织中分离核酸的方法
CN118792447A (zh) 位于1号染色体上与箭筈豌豆耐寒性相关的分子标记及应用
CN109652560B (zh) 与牦牛乳品质相关的遗传标记及其应用
JP2018512121A5 (enExample)
KR102112951B1 (ko) 암의 진단을 위한 ngs 방법
Maciejewska et al. A rare mutation in the primer binding region of the Amelogenin X homologue gene
US10939868B2 (en) Method of predicting rapid progression of fibrosis and therapy and reagents therefor
KR101557844B1 (ko) 이리도바이러스를 검출하기 위한 등온증폭 반응용 프라이머 세트, 이를 포함하는 프라이머 조성물, 및 이를 이용한 이리도바이러스 검출방법
CN111172241B (zh) 绵羊四碱基重复微卫星标记及其筛选方法、引物组和应用
de Carvalho et al. Influence of ACE I/D polymorphism on circulating levels of plasminogen activator inhibitor 1, D-Dimer, ultrasensitive C-reactive protein and transforming growth factor β1 in patients undergoing hemodialysis
JP2006223234A (ja) 遺伝子検査方法